Lo, Y.-L.; Wang, T.-Y.; Chen, C.-J.; Chang, Y.-H.; Lin, A.M.-Y.
Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer. Pharmaceutics 2022, 14, 1759.
https://doi.org/10.3390/pharmaceutics14091759
AMA Style
Lo Y-L, Wang T-Y, Chen C-J, Chang Y-H, Lin AM-Y.
Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer. Pharmaceutics. 2022; 14(9):1759.
https://doi.org/10.3390/pharmaceutics14091759
Chicago/Turabian Style
Lo, Yu-Li, Tse-Yuan Wang, Chun-Jung Chen, Yih-Hsin Chang, and Anya Maan-Yuh Lin.
2022. "Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer" Pharmaceutics 14, no. 9: 1759.
https://doi.org/10.3390/pharmaceutics14091759
APA Style
Lo, Y.-L., Wang, T.-Y., Chen, C.-J., Chang, Y.-H., & Lin, A. M.-Y.
(2022). Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer. Pharmaceutics, 14(9), 1759.
https://doi.org/10.3390/pharmaceutics14091759